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Arthritogenic alphaviruses including Ross River virus (RRV), Sindbis
virus, and chikungunya virus cause worldwide outbreaks of mus-
culoskeletal disease. The ability of alphaviruses to induce bone
pathologies remains poorly defined. Here we show that primary
human osteoblasts (hOBs) can be productively infected by RRV.
RRV-infected hOBs produced high levels of inflammatory cytokine
including IL-6. The RANKL/OPG ratio was disrupted in the synovial
fluid of RRV patients, and this was accompanied by an increase in
serum Tartrate-resistant acid phosphatase 5b (TRAP5b) levels. In-
fection of bone cells with RRV was validated using an established
RRV murine model. In wild-type mice, infectious virus was
detected in the femur, tibia, patella, and foot, together with re-
duced bone volume in the tibial epiphysis and vertebrae detected
by microcomputed tomographic (μCT) analysis. The RANKL/OPG
ratio was also disrupted in mice infected with RRV; both this effect
and the bone loss were blocked by treatment with an IL-6 neutral-
izing antibody. Collectively, these findings provide previously un-
identified evidence that alphavirus infection induces bone loss and
that OBs are capable of producing proinflammatory mediators
during alphavirus-induced arthralgia. The perturbed RANKL/OPG
ratio in RRV-infected OBs may therefore contribute to bone loss in
alphavirus infection.
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Arthritogenic alphaviruses including Ross River virus (RRV),chikungunya virus (CHIKV), Sindbis virus (SINV), o’nyong-
nyong virus (ONNV), and Barmah Forest virus (BFV) are clas-
sified under the genus Alphavirus (“Old World” alphaviruses) of
the Togaviridae family (1). RRV is a small, enveloped, positive-
sense single-stranded RNA virus transmitted by mosquitoes (2, 3).
RRV disease (RRVD) in humans commonly affects the ankles,
knees, and peripheral joints. The hallmarks of RRVD include
incapacitating joint pain and polyarthralgias, with a level of disability
comparable to rheumatoid arthritis (RA) (4, 5). Similar to RA, the
onset of RRVD can be sudden and debilitating, and the prolonged
manifestations of RRVD in some patients have been proposed to
be due to the actions of proinflammatory mediators including in-
terleukin-6 (IL-6), interleukin-1 (IL-1), and chemokine (C-C motif)
ligand 2; monocyte chemotactic protein-1 (CCL2; MCP-1) (6–8).
Recently, bone lesions in joints of CHIKV-infected patients
have been reported (9), providing evidence that alphavirus-
induced disease can result in bone pathologies (10, 11). In phys-
iological conditions, osteoblasts (OBs) form bone, and this cell
lineage also expresses both receptor activator of nuclear factor-
kappaB ligand (RANKL) and its soluble decoy receptor, osteo-
protegerin (OPG). The expression of RANKL by the OB lineage
is stimulated by IL-6 and IL-1β among other proinflammatory
cytokines (12, 13), whereas CCL2 is thought to be an important
chemoattractant for monocytic precursors during inflammatory
processes (14, 15). Together with an elevation in RANKL/OPG
ratio, this favors osteoclast (OC) formation from monocytic pre-
cursors (16, 17), leading to an increase in bone resorption and bone
pathologies (18, 19). Despite the vital role OBs play in bone
remodelling, their role in arthritogenic alphaviral infection and their
potential contributions to alphaviral disease are not yet known.
In this study, we investigate the susceptibility and response of
primary human OBs (hOBs) to RRV and the impact of RRV
infection on bone. RRV infection of hOBs resulted in increased
IL-6, IL-1β, and CCL2 together with an elevated RANKL/OPG
ratio. Using microcomputed tomography (μCT), we report that
alphavirus infection results in bone loss in an established RRV
murine model. Collectively, these findings reveal that RRV can
infect OBs and disrupt bone homeostasis, which may play an im-
portant role in alphavirus-induced arthritis by regulating proin-
flammatory cytokine/chemokine responses and pinpoint the sig-
nificance of IL-6 in modulating bone loss by disrupting the balance
of RANKL/OPG expression.
Results
RRV Replicates in Primary hOBs, Disrupts the RANKL/OPG Balance, and
Induces Production of Proinflammatory Cytokines. To investigate
OBs as a site of RRV replication, we assessed the ability of cul-
tured hOBs to support RRV replication. The cultured hOBs were
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phenotypically characterized (Fig. S1) and infected with RRV–
EGFP at a multiplicity of infection (MOI) of 1, 5, or 10. The virus
titer increased for all MOIs, peaking at 24 h postinfection (h.p.i.)
and declining to almost undetectable levels by 96 h.p.i. (Fig. 1A).
These findings demonstrate that hOBs are susceptible to infec-
tion by RRV and suggest OB as a cellular target for arthritogenic
alphaviruses.
Proinflammatory cytokines and chemokines are involved in
the pathogenesis of alphaviral arthritides (6, 7). At 24 and 96 h.p.i.,
we performed ELISA and qualitative RT-PCR (qRT-PCR) anal-
ysis to evaluate cytokine/chemokine levels in mock- and RRV-
infected hOBs. A correlation was observed between protein and
mRNA expression (Fig. S2A), where IL-6 and CCL2 were sig-
nificantly increased (P < 0.05) in RRV-infected hOBs compared
with mock controls (Fig. 1B). Similarly, IL-1β levels increased
significantly (P < 0.05) in response to RRV infection (Fig. S2 B
and C). TNF-α mRNA expression was transient and declined
to a level comparable to mock controls, although TNF-α protein
was not detected (Fig. S2 B and C). These findings show that RRV
infection of hOBs stimulated the production of proinflammatory
factors IL-6, CCL2 and IL-1β, which are known to promote
osteoclastogenesis (12, 20, 21).
To define the role of OBs in RRV infection, RANKL and
OPG were measured in the supernatants of mock- and RRV-
infected hOBs. At 24 and 96 h.p.i., RANKL levels were signifi-
cantly (P < 0.05) increased in RRV-infected hOBs. In contrast,
OPG was significantly (P < 0.05) lower in the RRV-infected
cultures compared with mock controls (Fig. 1C). As a result, the
RANKL/OPG ratio was markedly increased at 24 and 96 h.p.i.
(Fig. 1D). Therefore, RRV infection disrupts the RANKL/OPG
balance in hOBs, which suggests that RRV infection may affect
osteoclastogenesis.
Primary hOBs Enhance Osteoclastogenesis in Response to RRV Infection.
Osteoclastogenesis is regulated by OBs in the context of physi-
ological bone remodelling, and disruption of the RANKL/OPG
system can tilt the balance toward bone resorption (22). At 96
h.p.i., supernatants from RRV-infected hOBs were tested for their
ability to induce Tartrate-resistant acid phosphatase (TRAP)-
positive (TRAP+) multinuclear cells from mouse leukaemic
monocyte macrophage cell line (RAW264.7 cells) as a model of
osteoclastogenesis. As a positive control, RAW264.7 cells were
differentiated to TRAP+ cells using recombinant human
RANKL (hRANKL), in a process that could be inhibited using
recombinant human OPG (hOPG) (Fig. S3A). The dose-de-
pendent inhibition of hRANKL by hOPG is shown in Fig. S3B.
RAW264.7 cells were cultured with supernatants from RRV-
infected hOBs, and TRAP+ multinuclear cell formation was in-
hibited with the increasing levels of hOPG (Fig. 1E). The number
of TRAP+ cells decreased (P < 0.05) with increasing levels of
hOPG (Fig. 1F). RRV-infected RAW264.7 cells did not differ-
entiate into TRAP+ cells, suggesting that RRV-infected RAW264.7
cells alone cannot induce osteoclastogenesis in the absence of OBs
(Fig. S4A). Consistent with the results with hOBs, RAW264.7 cells
cultured with 24 h supernatant from RRV-infected primary murine
OBs (mOBs) showed a clear increase in TRAP+ cells after 6 d in
culture, compared with those treated with supernatant from mock-
infected OBs (Fig. S4B). Together, these data suggest that RRV
infection of OBs can induce osteoclastogenesis in a RANKL-
dependent manner.
RANKL/OPG Disruption in Synovial Fluid and Elevated Serum Levels of
TRAP5B in RRV Patients. Pathologic bone loss in inflammatory
arthritis is in part due to increased bone resorption, leading to an
imbalance in the coordinated action of bone-forming OBs and
bone-resorbing OCs (23, 24). In the synovial fluid of RRV pa-
tients, RANKL protein levels were higher, and OPG protein
levels were lower than in healthy controls (Fig. 2A). This resulted
in a markedly elevated RANKL/OPG ratio in RRV patients
(Fig. 2B). In addition, serum TRAP5b levels were significantly
(P < 0.05) higher in RRV patients (Fig. 2C), indicating increased
osteoclastogenesis in response to RRV infection.
Fig. 1. RRV replicates in primary hOBs and disrupts the RANKL/OPG ratio.
Primary hOBs were infected with RRV or treated with medium without virus
(mock). (A) The amount of infectious virus in the supernatants was de-
termined by plaque assay. Each data point represents the mean ± SEM of
primary hOBs from seven healthy individuals, performed in duplicate. *P <
0.001 using two-way ANOVA with Bonferroni posttest. (B) IL-6, CCL2, (C)
RANKL and OPG protein levels in mock- and RRV-infected hOBs supernatants
were determined by ELISA, and the (D) RANKL/OPG ratio is shown. Data
shown are mean ± SEM, performed in duplicate. *P < 0.05, using Student t
test, comparing mock- and RRV-infected. (E) Supernatants were tested for
the ability to induce TRAP+ multinuclear cells from RAW264.7 cells, in the
presence and absence of recombinant hOPG. RAW264.7 cells were cultured
either with 10 ng/mL, 2 ng/mL, or 0.4 ng/mL hOPG, or with supernatants
collected from RRV-infected hOBs at 96 h.p.i. Cells were stained for TRAP,
with no counterstaining, after 8 d and visualized using light microscopy
(20×). Arrows indicate TRAP+ cells. (F) The number of TRAP+ multinuclear
cells (OC-like cells) per well was quantified. Images shown are representative
of three independent experiments. Data are presented as mean ± SEM,
performed in triplicate. *P < 0.05 using one-way ANOVA with Tukey’s
posttest. S/N, supernatant.
Fig. 2. RRV infection perturbs the RANKL/OPG ratio in RRV-infected
patients. (A) Synovial fluid from healthy (n = 6) and RRV patients (n = 12)
were tested for RANKL and OPG protein levels, and the (B) RANKL/OPG ratio
is shown. (C) Serum from healthy (n = 10) and RRV patients (n = 14) was
tested for TRAP5b. Data are presented as mean ± SEM. Each symbol repre-
sents an individual patient.*P < 0.01 using Mann–Whitney U test.

















RRV Replicates in Murine Bone Cells and Induces Bone Loss. To de-
termine if RRV can replicate in bone, RRV-infected WT mice
were killed and the femur, tibia, patella, and foot collected for
measurement of virus titers by plaque assay, with high viral titers
detected in each of these sites (Fig. 3A). To further investigate if
RRV localizes in bone tissue during infection, mock- and RRV-
infected mice were killed and perfused with phosphate buffer
saline (PBS), and their hind limbs were decalcified and cry-
osectioned. RRV replication, observed as EGFP expression, was
detected in cells lining the periosteum of femur, tibia, and foot
and in the patella (Fig. 3B). In a separate experiment, we dem-
onstrated RRV replication in ex vivo OB-enriched cell prepa-
rations as determined by GFP expression (Fig. 3C). Although
RRV replication was detected in joint cell fractions, the virus
titers in fractions 3 and 4 (osteoblastic bone cells) were signifi-
cantly higher (P < 0.001) than in fractions 1 and 2 (bone marrow
cells, reticulocytes, and leukocytes) (Fig. S5A). Furthermore,
fraction 3 and 4 cultures maintained detectable RRV replication
until day 21 p.i., whereas RRV was only detectable in fractions 1
and 2 at day 1 p.i. (Table S1). In murine ex vivo OB cultures, the
gene transcripts of IL-6, CCL2, IL-1β, and, to a lesser extent,
TNF-α were clearly induced in response to RRV infection (Fig.
S5B). These findings indicate that OBs are targets for RRV in-
fection and are a source of proinflammatory factors during na-
tural infection.
Using the established murine model of RRV infection, the
impact of infection on bone architecture was evaluated by μCT.
By day 15 p.i., μCT imaging showed clear bone loss in the tibial
epiphysis, metatarsal joints, and vertebrae of RRV-infected mice,
suggesting that RRV-induced bone loss is systemic (Fig. 4 A and
B). In the tibial epiphysis and vertebrae of RRV-infected mice,
bone volume was reduced by 10%, accompanied by a decrease in
trabecular thickness (Tb.Th), as observed compared with saline-
injected controls (Fig. 4 C andD). In addition, the width of growth
plate and cortical bones of RRV-infected mice were significantly
reduced compared with control mice (Fig. 5 A and B), indicating
impairment in growth due to the infection. Histologic analysis also
confirmed increased TRAP+ OCs (Fig. S6) and bone loss in the
tibial epiphysis (Fig. 5C). These data are consistent with the dis-
rupted RANKL/OPG ratio and high TRAP5b levels observed in
RRV patients.
Fig. 3. RRV replicates in murine bones. Twenty-one–d-old C57BL/6 WT mice
were infected s.c. with 106 pfu of RRV–EGFP or with diluent alone. (A) At day 2
p.i., the femur, tibia, patella, and foot from mock- and RRV-infected mice (n =
10) were collected and homogenized, and the presence of infectious virus
determined by plaque assays. (B) Hind limbs of mock- and RRV-infected mice
were removed, fixed in 4% PFA, decalcified in 14% EDTA, and cryosectioned
(5 μm). Osteocalcin (red), replicating RRV–GFP (green, white arrows) and nuclei
(blue), was visualized by confocal microscopy. (Scale bar, 30 μm.) (C) Osteo-
blastic cell fractions (F3 and F4) were isolated from knee joints of C57BL/6 WT
mice and infected with RRV–EGFP at an MOI of 0.1 or with PBS (mock). At 24
h.p.i., mock- and RRV-infected bone tissues were visualized for EGFP by
fluorescence microscopy (20×). F1, fraction 1; F2, fraction 2; F3, fraction 3; F4,
fraction 4. DIC, differential interference contrast.
Fig. 4. Bone phenotype of RRV-infected C57BL/6
mice. μCT surface reconstruction performed in (A)
hind limbs and (B) L5 vertebrae of mock- and RRV-
infected WT mice (day 15 p.i.). BV/TV and Tb.Th in
the (C) proximal tibial epiphysis and (D) L5 vertebrae
of mock- and RRV-infected mice at day 15 p.i. are
shown. *P < 0.05, using Student t test, comparing
mock- and RRV-infected. Images of proximal tibial
epiphysis, foot, and vertebrae represent observa-
tions in 3–5 mice per group. Each symbol represents
a single mouse. Data represent mean ± SEM of 3–5
mice. F, foot; TE, tibial epiphysis.
6042 | www.pnas.org/cgi/doi/10.1073/pnas.1318859111 Chen et al.
IL-6 Neutralization Prevented RRV-Induced Increases in the RANKL/
OPG Ratio and Bone Loss. To investigate the role of IL-6 in
RRV-induced bone loss, hind limbs from WT mice and mice
treated with an IL-6 neutralizing antibody were collected at day
10 p.i. for μCT analysis. Reduced IL-6 protein levels in antibody-
treated mice at day 10 p.i. were confirmed by ELISA (Fig. S7A).
In response to RRV infection, WT mice showed severe bone loss
at day 10 p.i. compared with control mice (Fig. 6A). However,
IL-6 inhibition in RRV-infected mice ameliorated bone loss
(Fig. 6B), preserving bone volume/tissue volume (BV/TV) and
Tb.Th (Fig. 6C) compared with control RRV-infected mice. This
implicates IL-6 as a key mediator of RRV-induced bone loss.
The serum RANKL/OPG ratio in IL-6 neutralized mice was also
significantly (P < 0.001) reduced compared with infected control
mice, and did not differ from mock controls (Fig. 6D), suggesting
that IL-6 plays a significant role in triggering alphavirus-induced
bone loss in part by increasing the RANKL/OPG ratio. Although
IL-6 neutralization significantly reduced RRV clinical score
during early disease, it had no effect at peak RRVD (day 10 p.i.),
nor did it improve weight gain in these animals (Fig. S7B). RRV
titres in the ankle joints of IL-6 neutralized mice were signifi-
cantly reduced compared with isotype control mice (Fig. S7C),
suggesting that IL-6 also dampens viral clearance.
Discussion
Previous research on arthritogenic alphavirus-induced inflam-
mation has revealed that the progression of musculoskeletal
damage is mediated by proinflammatory cytokines and chemo-
kines produced in response to infection (25–27). However, the
exact mechanisms and inflammatory factors involved in alpha-
virus-induced arthralgia in bone tissues are not known. The sy-
novial fluid of RRV-infected patients showed an imbalanced
RANKL/OPG ratio, together with high serum TRAP5b levels,
suggesting that RRV infection can result in increased osteo-
clastogenesis. Abnormally high bone resorption contributes to
joint erosions and systemic bone loss, both hallmarks of RA.
Similarly, radiographic evidence of bone erosions has been
reported in CHIKV-infected patients (9, 28, 29). We demon-
strate that RRV infection results in bone loss using an estab-
lished murine model of RRV-induced arthritis. The proximal
tibial epiphysis, dorsal metatarsophalangeal joints of the foot,
and vertebrae of infected mice showed reduced bone volume,
suggesting that increased osteoclastogenesis in response to RRV
infection can induce bone loss. The murine model of RRV in-
fection showed severe disease signs characterized by reduced
growth plate width, hind-limb weakness, and dragging (25).
Replication of Sindbis-group alphaviruses has been described in
murine long bones (30), and here we demonstrate previously
unidentified high levels of infectious RRV in bones, specifically
the femur, tibia, foot, and patella. Cells lining the periosteum in
multiple bones of hind limbs were infected by RRV. In addition,
RRV infects murine ex vivo OB cells effectively during the early
phase of infection and support persistent infections up to day 21
p.i. Therefore, these findings suggest that RRV-infected osteo-
blastic cells may contribute to the pathogenesis of RRV-induced
polyarthritis.
OBs play an important role in regulating osteoclastogenesis
through their regulated expression of RANKL and OPG, with
an increased RANKL/OPG ratio creating proosteoclastic con-
ditions within the local bone microenvironment (22, 24). Non-
osteoblastic cells with elevated RANKL expression, such as T
cells and synovial fibroblasts, also contribute to regulating OC
differentiation and bone loss in inflammatory arthritis (20, 31).
In response to RRV infection, hOBs showed an increase in RANKL
expression, whereas OPG expression decreased. Hence, our find-
ings highlight the potential role of OBs in RRV pathogenesis and
provide previously unidentified evidence of OB involvement in
alphaviral-induced disease. OBs interact with precursor monocytic
cells through RANKL/RANK to induce maturation of OCs in vivo
(32). This system can be modeled in vitro using RAW264.7 cells,
which have the capacity to differentiate into TRAP+ multinuclear
OCs in the presence of hRANKL (33). RRV-infected hOBs en-
hanced osteoclastogenesis through disruption of the RANKL/OPG
ratio. This result is consistent with an increase in circulating serum
TRAP5b in RRV patients. Recently, alterations in the RANKL/
OPG ratio have been reported in CHIKV-infected hOBs (11),
suggesting that our findings may be broadly applicable to other
arthritogenic viruses. Therefore, the elevation in RANKL and
suppression of OPG expression highlight the likelihood that OBs
may play an important role in the development of persistent mus-
culoskeletal symptoms in arthritogenic alphavirus-induced disease.
Our work also demonstrates that IL-6 is a critical mediator of
the RRV-induced increase in RANKL/OPG ratio and bone loss.
Several inflammatory cytokines and chemokines play key roles in
both the regulation of factors that influence bone remodelling
and the pathogenesis of alphavirus infection (34). In alphavirus-
induced arthralgia, IL-6 is expressed in affected joints (35) and
a role for IL-6 in determining alphavirus disease severity has
been proposed (7, 26). Skeletal muscles (36) and cells of bones
(37) can produce IL-6, which is highly elevated and associated
with persistent arthralgia in chronic alphaviral infections (7, 38).
IL-6 is a pleiotropic cytokine important in regulating immune
responses and bone metabolism in diseases such as osteoporosis
and Paget disease (39, 40), and mediates increased osteoclasto-
genesis in murine models of ovariectomy-induced (41) and
Fig. 5. RRV infection reduces growth plate width and cortical bone thickness.
(A) Paraffin-sectioned (5 μm) sections from proximal tibia of mock- and RRV-
infected WT mice were stained with Masson’s trichrome stain at day 10 and 15
after infection (20×). Representative images from three to five mice per group
are shown. (B) The width of cortical bones and growth plates of mock- and RRV-
infectedWTmice from five areas weremeasured. Data represent mean ± SEM of
3–5 mice per group. *P < 0.05 using one-way ANOVA with Turkey’s posttest. (C)
Plastic-embedded sections (5 μm) of tibiae frommock- and RRV-infectedmice are
stained with von Kossa stain at day 10 and 15 after infection (20×). C, cortical
bone; GP, growth plate; M, muscles; TE, tibial epiphysis.

















arthritic (42) bone loss. In addition, IL-6 has a central role in the
up-regulation of RANKL in OBs (10, 11), the induction of CCL2
(43), and the development of joint pain (44). In fact, low bone
mass and high OC numbers have been reported in the growing
skeleton of transgenic IL-6 mice, a model of chronic inflamma-
tion (45). We have shown that RRV-induced bone loss is ame-
liorated in the absence of IL-6, suggesting that IL-6 is a crucial
osteotropic factor that regulates bone loss during RRVD.
Our work provides unique insights into the bone pathophysiology
in alphavirus-induced arthralgia. The alteration in the RANKL/
OPG ratio toward bone resorption contributes to increasing
osteoclastogenesis and possibly the aggravation of arthralgia after
RRV infection. Our study highlights a possible OB-mediated
mechanism that contributes to inflammation-induced bone loss
following RRV infection through RANKL-mediated osteoclas-
togenesis. We showed that IL-6 is essential for bone loss during
RRV infection and inhibition of IL-6 alleviates inflammation
during early RRVD but not in later stages of the disease, sug-
gesting that RRV-induced bone loss may be driven by early in-
flammatory responses. Therefore, targeting IL-6 in early RRVD
using anti–IL-6R antibodies, such as tocilizumab, will likely be
therapeutically beneficial in the prevention of RRV-induced
bone loss.
Materials and Methods
Viruses. Stocks of T48 strain of RRV (RRV-T48) were generated from the full-
length T48 cDNA clone (46). Stocks of RRV that expressed EGFP were kindly
provided by Mark Heise (University of North Carolina at Chapel Hill, Chapel
Hill, NC). RRV titres were determined by plaque assay on Vero cells as de-
scribed previously (47).
Mice. C57BL/6 WT mice were obtained from the Animal Resource Centre and
bred in-house. The 21-d-old male and female mice, of equal distribution, were
inoculated s.c. in the thorax below the right forelimb with 104 pfu of RRV-T48
or 106 pfu of RRV–EGFP diluted in PBS as described (47). Mice were monitored
daily for diet and well-being. Mice were weighted and scored for disease signs
every 24 h as described previously (27). All animal experiments were approved
by the Animal Ethics Committee of Griffith University (BDD/06/11/AEC).
IL-6 Neutralization in Vivo. Twenty-one-d-old WT mice received injections of
neutralizing anti–IL-6 antibody (MP5-20F3, BioXcell) or Rat IgG1 isotype
control: 500 μg intraperitoneally at day 0 and at days 2, 4, 6, and 8 p.i. Mice
were killed and serum collected at day 10 postinfection. Hind limbs were
fixed in 4% (wt/vol) paraformaldehyde (PFA) and stored in 70% ethanol.
Histology. Mice were killed, hind limbs collected, fixed in 4% (wt/vol) PFA,
decalcified, and embedded in paraffin or plastic. Fivemicrometer sections were
prepared and stained with TRAP, Masson’s trichrome, and von Kossa stains.
Primary Cell Cultures. Primary mOBs were obtained from the calvarial bones
of C57BL/6 WT mice, of equal sex distribution, as described previously with
minor modifications (48). Murine joint cell fractions were generated
according to the amount of time exposed to collagenase digestion as de-
scribed previously (30, 49). Primary hOBs were obtained from trabecular
bone specimens of seven healthy individuals (four males, three females)
aged 50–60 y undergoing orthopedic operations for causes unrelated to
arthritis or osteoporosis. The hOBs were cultured from bone fragments as
described previously (50). See SI Materials and Methods for details.
Patient Samples. Convalescent serum samples from 14 RRV patients (age range,
21–66 y; male to female ratio, 7:7) serologically confirmed with IgG anti-RRV
were provided by Andrew Lloyd (University of New South Wales, Kensington,
Australia). Serum samples from 13 healthy individuals (age range, 18–65 y;
male to female ratio, 7:6) were provided by the Australian Red Cross. Twelve
synovial fluid samples from patients with RRV-induced polyarthritis (age
range, 30–45 y; male to female ratio, 6:6) were provided by The Royal Mel-
bourne Hospital. Synovial fluids from six healthy individuals (age range, 47–60
y; male to female ratio, 3:3) for causes unrelated to arthritis or osteoporosis
were provided by Australian National University Medical School. All human
samples were collected with informed consent and human ethics approval.
OC-Like Cell Differentiation Assays. RAW264.7 cells were cultured with su-
pernatant from RRV-infected hOBs. After 8 d in culture, cells were fixed for
detection of TRAP enzyme activity. See SI Materials and Methods for details.
TRAP Histochemical Staining. Cells were fixed in 4% (wt/vol) PFA, and TRAP
enzyme activity was detected using Sigma-Aldrich kit 387-A according to the
manufacturer’s instructions. For in vitro inhibition of TRAP+ cell differenti-
ation, see SI Materials and Methods for details.
Fig. 6. Treatment with IL-6 neutralizing antibody
ameliorates RRV-induced bone loss in C57BL/6 mice.
μCT surface reconstruction performed in hind limbs
from RRV-infected (A) WT and (B) IL-6 neutralized
mice at day 10 after infection. Images of proximal
tibial epiphysis represent observations in 3–5 mice
per group. (C) BV/TV, Tb.Th in the proximal tibial
epiphysis, and (D) RANKL/OPG ratio in the serum
from mock- or RRV-infected and Rat IgG1 isotype
control or IL-6 neutralizing antibody treated mice at
day 10 p.i. are shown. *P < 0.05 using one-way
ANOVA with Turkey’s posttest. Each symbol repre-
sents a single mouse. Data represent mean ± SEM of
3–5 mice per group.
6044 | www.pnas.org/cgi/doi/10.1073/pnas.1318859111 Chen et al.
μCT. μCT analyses were performed on murine hind limbs with Skyscan 1076
μ-CT system (Skyscan). BV/TV and Tb.Th were determined using CTAN (Sky-
scan). See SI Materials and Methods for details.
ELISAs. See SI Materials and Methods for details.
Plaque Assays. See SI Materials and Methods for details.
qRT-PCR. See SI Materials and Methods for details.
Immunofluorescence. See SI Materials and Methods for details.
Statistical Analysis. Viral titers, RT-PCR, ELISA, clinical scores, and bone density
analysis were statistically evaluated by two-tailed unpaired Student t tests or
one-way ANOVA with Tukey’s posttest. Plaque assays for primary hOBs,
weight gain, and clinical scores were analyzed by two-way ANOVA with
Bonferroni posttest. TRAP+ cell quantification, cortical bone, and growth
plate thickness were analyzed by one-way ANOVA with Tukey’s posttest. All
data were assessed for Gaussian distribution using the D’Agostino–Pearson
normality test before analysis with these parametric tests. Statistics were
performed with GraphPad Prism 5.02.
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